This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
protein
product name :
RECOMBINANT HUMAN INTERFERON BETA 1 ALPHA
catalog :
OBT1546A
quantity :
5 µg
price :
193 USD
product information
Entity Type :
Recombinant Protein
Entity Category :
Antigens and Lysates
ProductCode :
OBT1546A
Description :
RECOMBINANT HUMAN INTERFERON BETA 1 ALPHA
Specificity :
IFN BETA 1A
TargetSpecies :
Human
Format :
Rec. Protein
Applications :
FN
ApplicationTypes :
Functional Assays
Quantity :
5 µg
Quantity Value :
5
Quantity Type :
µg
GO Accessions :
GO:0003714,GO:0007596,GO:0005125,GO:0005615,GO:0005132,GO:0006917,GO:0008285,GO:0006919,GO:0010552,GO:0030101,GO:0042100,GO:0032897,GO:0045071,GO:0045089,GO:0046597,GO:0045343,GO:0060337,GO:0051607,GO:0071360,GO:0060338
GOTerms :
transcription co-repressor activity,blood clotting,autocrine activity,paracrine activity,interferon-alpha/beta,interferon-alpha/beta receptor ligand,intercellular space,activation of apoptosis,apoptosis activator activity,apoptosis signaling,commitment to apoptosis,induction of apoptosis by p53,caspase activation,down regulation of cell proliferation,downregulation of cell proliferation,down-regulation of cell proliferation,inhibition of cell proliferation,NK cell activation,down regulation of viral transcription,downregulation of viral transcription,down-regulation of viral transcription,inhibition of viral transcription,B lymphocyte proliferation,B-cell proliferation,B-lymphocyte proliferation,GO:0042114,down regulation of viral genome replication,downregulation of viral genome replication,down-regulation of viral genome replication,inhibition of viral genome replication,stimulation of innate immune response,up regulation of innate immune response,upregulation of innate immune response,up-regulation of innate immune response,regulation of major histocompatibility complex class I biosynthesis,regulation of major histocompatibility complex class I biosynthetic process,regulation of MHC class I anabolism,regulation of MHC class I biosynthesis,regulation of MHC class I formation,regulation of MHC class I synthesis,down regulation of virion penetration into host,downregulation of virion penetration into host,down-regulation of virion penetration into host,inhibition of virion penetration into host,antiviral response,defence response to virus,defense response to viruses,type I interferon-mediated signalling pathway,regulation of type I interferon-mediated signalling pathway,cellular response to exogenous double-stranded RNA,cellular response to viral dsRNA
Uniprot Accessions :
P01574
Gene :
IFNB1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3456
Published Synonyms :
INTERFERON BETA
Entity Formats :
Rec. Protein
UNSPSC :
12352202
Concentration :
Total protein concentration 0.1 mg/ml after reconstitution
Product Form :
Recombinant protein - lyophilized
PriceGBP :
102
PriceEUR :
150
PriceUSD :
193 USD
PriceCHF :
163
PriceSEK :
1635
PriceNOK :
1643
PriceDKK :
1118
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.